Project Grant HT94252510530
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$500K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
585 Av. Franklin Delano Roosevelt Ste 202, San Juan, 00936, Puerto Rico
Similar Awards
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded the University of Puerto Rico Medical Sciences Campus (UPR-MSC) a $1,048,900 project grant on February 15, 2024. This 3-year grant supports research to investigate the use of Rac/Cdc42 inhibitors for metastasis prevention in the breast cancer tumor microenvironment. As a minority-serving, Hispanic-serving, and academic medical institution, UPR-MSC has extensive expertise in areas like cancer,...
The University of Puerto Rico Medical Sciences Campus will receive $1.3 million under a three-year Project Grant award from the Defense Health Agency to support translational development of MBQ-167 as a targeted therapy for metastatic breast cancer. Through the Military Medical Research and Development program (CFDA 12.420), the award will fund applied and advanced biomedical research efforts aimed at transforming healthcare for service members and the general public. Specifically, the...
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
This federal Project Grant award of $1,592,860.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The award was granted to the Rector & Visitors of the University of Virginia, a prominent academic research institution, to conduct ultrasensitive proteomics research for type 1 diabetes prediction and treatment efficacy...
This $993,283 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Francisco (UCSF) aimed at transforming healthcare for military service members, veterans, and the broader public. The 2-year award, effective from September 1, 2025 to August 31, 2027, will fund proteomic research to investigate determinants and components of disease progression in multiple...
This federal Project Grant award of $437,967.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Diego (UCSD) focused on arterial disease in vascular Ehlers-Danlos syndrome and the potential role of oxidative stress. The award, effective January 1, 2025 through December 31, 2026, will fund comprehensive research services and scientific investigations at UCSD, a renowned...
The University of Arizona was awarded a $1,791,407 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "Targeting Drug Resistance in the Bone Microenvironment Using a Novel PIM-PROTAC". The 3-year grant, running from March 1, 2025 to February 29, 2028, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The funding will...
This federal Project Grant award for $3,854,000.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is funding research at the University of Massachusetts Medical School (UMass Medical) to target human respiratory viruses and host sequences with respiratory-active RNAs. The award, which runs from September 1, 2025 to August 31, 2029, supports advanced biomedical research aimed at transforming healthcare for military service...
This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
This federal Project Grant award of $433,126 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Texas Health Science Center at San Antonio (UTHSCSA) to explore the role of PACAP38 in post-traumatic headache. The research aims to investigate innovative medical solutions for the battlefield and transform healthcare for service members and the broader public. UTHSCSA is a prominent Hispanic-serving academic...